Machine Learning Model to Predict Colorectal Cancer |
Bence Lukacsy |
Barrington High School |
PLCO |
Nov 9, 2022 |
PLCO-1097 |
Clarifying Lung Cancer Risk Among Breast Cancer Survivors |
Keith Sigel |
The Mount Sinai Hospital |
PLCO |
Nov 9, 2022 |
PLCO-1092 |
Effect of risk-stratified screening with flexible sigmoidoscopy on colorectal cancer incidence and mortality |
Yubei Huang |
Tianjin Medical University Cancer Institute and Hospital |
PLCO |
Nov 4, 2022 |
PLCO-1094 |
What does the National Lung Cancer Screening Trial imply for the effectiveness of computerized tomography screening in the US population? |
Issa Dahabreh |
Harvard University |
NLST |
Nov 2, 2022 |
NLST-983 |
Reexamine trial outcomes in PLCO to identify interactions of screening effects with screen results and other covariates |
Hormuzd Katki |
NCI |
PLCO |
Nov 1, 2022 |
PLCO-1091 |
Association between Changes among Multiple Rounds Chest X-ray and Lung Cancer Risk in Two Screening Trials |
Ya Liu |
Tianjin Medical University Cancer Institute and Hospital |
NLST |
Nov 1, 2022 |
NLST-982 |
Progression and regression in chest X-ray with lung cancer incidence and mortality in Two Screening Trials |
Ya Liu |
Tianjin Medical University Cancer Institute and Hospital |
PLCO |
Nov 1, 2022 |
PLCO-1090 |
Association between use of non-steroidal anti-inflammatory drugs (NSAIDs) and risk of pancreatic cancer in a national prospective cohort study |
Yunpeng Yu |
Indiana University |
PLCO |
Nov 1, 2022 |
PLCO-1088 |
Deep learning for indirect and direct cardiovascular risk estimation from ungated chest CT |
Piotr Slomka |
Cedars-Sinai |
NLST |
Nov 1, 2022 |
NLST-981 |
Colorectal cancer predicting model established on a large prospective screening project. |
Ziqi Zhang |
Sun Yat-Sen University Cancer Center |
PLCO |
Nov 1, 2022 |
PLCO-1087 |
ANALYSIS OF THE EFFECT OF CHEMOTHERAPY IN OVARIAN CANCER TREATMENT USING DATA MINING |
Kezban Alpan |
Middlesex University |
PLCO |
Nov 1, 2022 |
PLCO-1089 |
Time Lag to Benefit: A Systematic Review and Meta-Analysis of Lung Cancer Screening Trials |
Alison Rustagi |
University of California, San Francisco |
LSS |
Oct 27, 2022 |
LSS-3 |
Self-supervised learning for covid-19 diagnosis via Chest X-Rays |
Wenqiang LI |
The Hong Kong University of Science and Technology |
PLCO |
Oct 27, 2022 |
PLCOI-1085 |
Diabetes risk reduction diet and colorectal carcinogenesis: a prospective cohort study |
Chengcheng Liu |
The Second Affiliated Hospital, Zhejiang University School of Medicine |
PLCO |
Oct 27, 2022 |
PLCO-1082 |
Integrating genetic susceptibility, blood biomarkers, and traditional factors to develop risk-adapted colonoscopy surveillance strategies |
Chengcheng Liu |
The Second Affiliated Hospital, Zhejiang University School of Medicine |
PLCO |
Oct 27, 2022 |
PLCO-1083 |
Assessing the effect of different kinds of explanations on how much people trust a cancer diagnosis |
Ben Armstrong |
Massachusetts Institute of Technology |
PLCO |
Oct 27, 2022 |
PLCO-1080 |
Development of CAD for lung nodule screening |
Naïm Jalal |
GE HEALTHCARE |
NLST |
Oct 27, 2022 |
NLST-977 |
Alcohol Intake Across the Life Course and Risk of Ovarian Cancer in Postmenopausal Women |
Alexandra Schmidt |
University of North Dakota |
PLCO |
Oct 19, 2022 |
PLCO-1078 |
Survival analysis based on pathological images of lung cancer patients |
xiaofei xia |
Anhui University |
NLST |
Oct 19, 2022 |
NLST-976 |
Synthetic generation and tagging of CXR and pathology images |
Jonathan Pearson |
NHS Commissioning Board (NHS England) |
PLCO |
Oct 18, 2022 |
PLCOI-1077 |